Related Experiment Videos
Androgen replacement therapy in women
1Division of Medical Sciences, Institute of Biomedical Research, Endocrinology, Birmingham, UK. w.arlt@bham.ac.uk
Current Opinion in Investigational Drugs (London, England : 2000)
|November 2, 2005
Summary
Androgen deficiency in women due to adrenal or ovarian loss can improve with androgen replacement therapy, particularly enhancing libido and mood. Menopause does not always require androgen therapy, and effective administration methods are still under development.
Area of Science:
- Endocrinology
- Women's Health
- Reproductive Medicine
Background:
- Androgens in women originate from ovarian production or adrenal conversion of dehydroepiandrosterone.
- Loss of ovarian or adrenal function, seen in Addison's disease or after oophorectomy, typically leads to significant androgen deficiency.
- Physiological menopause is not consistently linked to androgen deficiency, thus not routinely necessitating androgen therapy.
Purpose of the Study:
- To review the role of androgens in women's physiology.
- To evaluate the effects of androgen replacement therapy in women with androgen deficiency.
- To discuss the challenges in androgen administration for women.
Main Methods:
- Literature review of physiological androgen production in women.
- Analysis of studies on androgen replacement therapy outcomes.
- Discussion of current challenges in androgen administration for women.
Main Results:
- Androgen replacement therapy can significantly improve libido and mood in women with adrenal or ovarian insufficiency.
- Limited randomized controlled trials exist for androgen use in women.
- No androgen preparations are currently FDA-approved for women.
Conclusions:
- Androgen replacement is beneficial for women with specific conditions causing androgen deficiency.
- Further research is needed to establish optimal androgen administration strategies for women.
- Androgen therapy is not routinely indicated for physiological menopause.